Transpact Enterprises Limited
BSE: TRANSPACT · Medical Equipment & Supplies
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Transpact Enterprises Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Transpact Enterprises Limited is an Indian med-tech company specialising in the design and commercialisation of therapeutic and rehabilitation devices. The firm focuses on developing assistive technology for individuals with neuro-muscular disabilities, such as cerebral palsy.
Business Model
The company generates revenue through the development and sale of proprietary medical devices, leveraging indigenous innovation and intellectual property. It maintains a research-led approach, often collaborating with academic institutions to produce cost-effective healthcare solutions.
Growth Outlook
Growth is driven by the expansion of its rehabilitation technology portfolio and the commercialisation of its flagship Digitizer device. The company aims to capture market share in the niche segment of indigenous medical devices through continued research and development.
Key Risks
- Regulatory Risk. The company is subject to stringent medical device regulations and quality standards which may impact product approval timelines.
- Market Adoption. As a niche player, the company faces challenges in scaling the adoption of its specialised rehabilitation devices within the broader healthcare market.
- Competition. The medical technology sector is highly competitive, with potential pressure from both established global players and low-cost domestic manufacturers.
- R&D Dependency. The company's future success is heavily reliant on the continuous development of intellectual property and successful collaboration with academic partners.
Start your research today
Unlock AI insights, financials, peers and live data on Transpact Enterprises Limited and 5,000+ companies — free.
Peers · Medical Equipment & Supplies
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Transpact Enterprises LimitedTRANSPACT | ₹3 Cr | — | — | — | 66.7% | — | — | -49.6% |
Tarsons ProductsTARSONS | ₹1,768 Cr | 158.97 | 14.57 | 10.6% | 33.1% | 1.8% | 4.5% | +6.6% |
Laxmi DentalLAXMIDENTL | ₹1,098 Cr | 35.30 | 19.82 | — | 19.2% | 13.7% | 13.3% | -41.5% |
Vasa Denticity LimitedDENTALKART | ₹709 Cr | — | — | — | 4.0% | — | — | -34.1% |
Hemant Surgical Industries LimitedHSIL | ₹539 Cr | — | — | — | 10.0% | — | — | +27.0% |
Prevest DenproPREVEST | ₹464 Cr | — | — | — | 36.0% | — | — | -31.5% |
As of Mar 2026
Financials
Transpact Enterprises Limited
BSE: TRANSPACT · Medical Equipment & Supplies
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Transpact Enterprises Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Transpact Enterprises Limited is an Indian med-tech company specialising in the design and commercialisation of therapeutic and rehabilitation devices. The firm focuses on developing assistive technology for individuals with neuro-muscular disabilities, such as cerebral palsy.
Business Model
The company generates revenue through the development and sale of proprietary medical devices, leveraging indigenous innovation and intellectual property. It maintains a research-led approach, often collaborating with academic institutions to produce cost-effective healthcare solutions.
Growth Outlook
Growth is driven by the expansion of its rehabilitation technology portfolio and the commercialisation of its flagship Digitizer device. The company aims to capture market share in the niche segment of indigenous medical devices through continued research and development.
Key Risks
- Regulatory Risk. The company is subject to stringent medical device regulations and quality standards which may impact product approval timelines.
- Market Adoption. As a niche player, the company faces challenges in scaling the adoption of its specialised rehabilitation devices within the broader healthcare market.
- Competition. The medical technology sector is highly competitive, with potential pressure from both established global players and low-cost domestic manufacturers.
- R&D Dependency. The company's future success is heavily reliant on the continuous development of intellectual property and successful collaboration with academic partners.
Start your research today
Unlock AI insights, financials, peers and live data on Transpact Enterprises Limited and 5,000+ companies — free.
Peers · Medical Equipment & Supplies
As of Mar 2026